← Back to catalogue

Novocastra™

FDA UDI

Class I (US FDA UDI)

by Leica Biosystems Newcastle, Limited

Identity

Trade Name
Novocastra™ FDA UDI
Generic Name
Human epidermal growth factor receptor 2 (HER2) protein IVD, antibody FDA UDI
Device Name
NCL-L-CB11 is intended for the qualitative identification by light microscopy of c-erbB-2 Oncoprotein molecules in paraffin sections. FDA UDI
Model / Reference
CB11-L-CE FDA UDI
Description
NCL-L-CB11 is intended for the qualitative identification by light microscopy of c-erbB-2 Oncoprotein molecules in paraffin sections. FDA UDI

Identifiers

Catalog Number
NCL-L-CB11 FDA UDI
Primary DI / UDI-DI
05055331315304 FDA UDI
FDA Product Code
NJT FDA UDI
GMDN Term
Human epidermal growth factor receptor 2 (HER2) protein IVD, antibody FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Human epidermal growth factor receptor 2 (HER2) protein IVD, antibody

Novocastra™ by Leica Biosystems Newcastle, Limited — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Human epidermal growth factor receptor 2 (HER2) protein IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI c0a0bf3e-b8ec-48e2-b814-7c4e476139ce 36 fields · synced May 30, 2026